Literature DB >> 20718859

Staphylococcus aureus elongation factor G--structure and analysis of a target for fusidic acid.

Yang Chen1, Ravi Kiran Koripella, Suparna Sanyal, Maria Selmer.   

Abstract

Fusidic acid (FA) is a bacteriostatic antibiotic that locks elongation factor G (EF-G) on the ribosome in a post-translocational state. It is used clinically against Gram-positive bacteria such as pathogenic strains of Staphylococcus aureus, but no structural information has been available for EF-G from these species. We have solved the apo crystal structure of EF-G from S. aureus to 1.9 Å resolution. This structure shows a dramatically different overall conformation from previous structures of EF-G, although the individual domains are highly similar. Between the different structures of free or ribosome-bound EF-G, domains III-V move relative to domains I-II, resulting in a displacement of the tip of domain IV relative to domain G. In S. aureus EF-G, this displacement is about 25 Å relative to structures of Thermus thermophilus EF-G in a direction perpendicular to that in previous observations. Part of the switch I region (residues 46-56) is ordered in a helix, and has a distinct conformation as compared with structures of EF-Tu in the GDP and GTP states. Also, the switch II region shows a new conformation, which, as in other structures of free EF-G, is incompatible with FA binding. We have analysed and discussed all known fusA-based fusidic acid resistance mutations in the light of the new structure of EF-G from S. aureus, and a recent structure of T. thermophilus EF-G in complex with the 70S ribosome with fusidic acid [Gao YG et al. (2009) Science326, 694-699]. The mutations can be classified as affecting FA binding, EF-G-ribosome interactions, EF-G conformation, and EF-G stability.
© 2010 The Authors Journal compilation © 2010 FEBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718859     DOI: 10.1111/j.1742-4658.2010.07780.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  22 in total

1.  Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid.

Authors:  Georgina Cox; Gary S Thompson; Huw T Jenkins; Frank Peske; Andreas Savelsbergh; Marina V Rodnina; Wolfgang Wintermeyer; Steve W Homans; Thomas A Edwards; Alexander J O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

Review 2.  Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors:  Prabhavathi Fernandes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

3.  A central interdomain protein joint in elongation factor G regulates antibiotic sensitivity, GTP hydrolysis, and ribosome translocation.

Authors:  Cristina Ticu; Marat Murataliev; Roxana Nechifor; Kevin S Wilson
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

4.  Mechanism of elongation factor-G-mediated fusidic acid resistance and fitness compensation in Staphylococcus aureus.

Authors:  Ravi Kiran Koripella; Yang Chen; Kristin Peisker; Cha San Koh; Maria Selmer; Suparna Sanyal
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

5.  Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.

Authors:  Lynette M Phee; Jonathan W Betts; Binutha Bharathan; David W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

6.  Movement of elongation factor G between compact and extended conformations.

Authors:  Enea Salsi; Elie Farah; Zoe Netter; Jillian Dann; Dmitri N Ermolenko
Journal:  J Mol Biol       Date:  2014-11-15       Impact factor: 5.469

7.  Structure of the ribosome with elongation factor G trapped in the pretranslocation state.

Authors:  Axel F Brilot; Andrei A Korostelev; Dmitri N Ermolenko; Nikolaus Grigorieff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

8.  The conserved GTPase HflX is a ribosome splitting factor that binds to the E-site of the bacterial ribosome.

Authors:  Mackenzie L Coatham; Harland E Brandon; Jeffrey J Fischer; Tobias Schümmer; Hans-Joachim Wieden
Journal:  Nucleic Acids Res       Date:  2016-01-04       Impact factor: 16.971

9.  Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile.

Authors:  Martin Garcia Chavez; Alfredo Garcia; Hyang Yeon Lee; Gee W Lau; Erica N Parker; Kailey E Komnick; Paul J Hergenrother
Journal:  ACS Infect Dis       Date:  2021-02-01       Impact factor: 5.084

10.  Distinct mechanisms of the human mitoribosome recycling and antibiotic resistance.

Authors:  Ravi Kiran Koripella; Ayush Deep; Ekansh K Agrawal; Pooja Keshavan; Nilesh K Banavali; Rajendra K Agrawal
Journal:  Nat Commun       Date:  2021-06-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.